Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer

Condition:   Triple Negative Breast Cancer Intervention:   Drug: oral etoposide + anlotinib Sponsor:   Chinese Academy of Medical Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials